Cargando…
Development and Evaluation of Physiologically Based Pharmacokinetic Drug–Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations
The physiologically based pharmacokinetic (PBPK) approach facilitates the construction of novel drug–disease models by allowing incorporation of relevant pathophysiological changes. The aim of the present work was to explore and identify the differences in rifampicin pharmacokinetics (PK) after the...
Autores principales: | Rasool, Muhammad F., Khalid, Sundus, Majeed, Abdul, Saeed, Hamid, Imran, Imran, Mohany, Mohamed, Al-Rejaie, Salim S., Alqahtani, Faleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921057/ https://www.ncbi.nlm.nih.gov/pubmed/31694244 http://dx.doi.org/10.3390/pharmaceutics11110578 |
Ejemplares similares
-
Physiologically
Based Pharmacokinetic
Model To Predict Metoprolol Disposition in Healthy and Disease Populations
por: Zamir, Ammara, et al.
Publicado: (2023) -
A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications
por: Khalid, Sundus, et al.
Publicado: (2021) -
Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease
por: Khalid, Sundus, et al.
Publicado: (2023) -
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases
por: Rasool, Muhammad F., et al.
Publicado: (2021) -
A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
por: Talha Zahid, Muhammad, et al.
Publicado: (2023)